Prospective study of the use of healthcare resources and economic costs in patients with fibromyalgia after treatment in routine medical practice

Clinical and Experimental Rheumatology

Volumn 30, Issue SUPPL.74, 2012, Pages

  Rivera, Javier ^a   Rejas Gutiérrez, Javier ^b   Vallejo, Miguel A ^c   Esteve Vives, Joaquim ^d   De Salas Cansado, Marina ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b PFIZER INC   (United States)

^c UNIVERSIDAD NACIONAL DE EDUCACIÓN A DISTANCIA   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Fibromyalgia; Health care costs; Health resources; Prospective studies; Spain

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE;

ACUPUNCTURE; ADULT; AGE; ARTICLE; CHIROPRACTIC; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DRUG COST; ELECTROSTIMULATION THERAPY; EMPLOYMENT STATUS; FEMALE; FIBROMYALGIA; GENDER; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; HYDROTHERAPY; LOST WORKDAY EQUIVALENT; MAJOR CLINICAL STUDY; MALE; MASSAGE; MEDICAL LEAVE; MEDICAL PRACTICE; OBSERVATIONAL STUDY; OSTEOPATHIC MEDICINE; OZONE THERAPY; PHYSIOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOTHERAPY; RELAXATION TRAINING; SPAIN; WORKING TIME; ABSENTEEISM; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; ECONOMICS; EMPLOYMENT; HEALTH CARE PLANNING; MIDDLE AGED; MULTICENTER STUDY; NATIONAL HEALTH SERVICE; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; UTILIZATION REVIEW;

ABSENTEEISM; ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DRUG COSTS; EMPLOYMENT; FEMALE; FIBROMYALGIA; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SICK LEAVE; SPAIN; STATE MEDICINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84874961374     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. WOLFE F, ROSS K, ANDERSON J et al.: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19-28.
2. MAS AJ, CARMONA L, VALVERDE M et al.; EPISER STUDY GROUP: Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Clin Exp Rheumatol 2008; 26: 519-26.
3. WOLFE F, ANDERSON J, HARKNESS D et al.: A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 1997; 40: 1560-70.
4. WHITE KP, SPEECHLEY M, HARTH M et al.: The London fibromyalgia epidemiology study: direct health care cost of fibromyalgia syndrome in London, Canada. J Rheumatol 1999; 26: 885-9.
5. ROBINSON RL, BIRNBAUM HG, MORLEY MA et al.: Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol 2003; 30: 1318-25.
6. HUGHES G, MARTINEZ C, MYON E et al.: The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 2006; 54: 177-83.
7. BERGER A, DUKES E, MARTIN S et al.: Characteristics and health care costs of patients with fibromyalgia syndrome. Int J Clin Pract 2007; 61: 1498-508.
8. BOONEN A, VAN DEN HEUVEL R, VAN TUBERGEN A et al.: Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondilytis. Ann Rheum Dis 2005; 64: 396-402.
9. WHITE LA, BIRNBAUM HG, KALTENBOECK A et al.: Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med 2008; 50: 13-24.
10. MARCINIAK M, LAGE MJ, LANDBLOOM RP et al.: Medical and productivity costs of anxiety disorders: Case control study. Depress Anxiety 2004; 19: 112-20.
11. SICRAS-MAINAR A, REJAS J, NAVARRO R et al.: Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study. Arthritis Res Ther 2009; 11: R54.
12. RIVERA J, REJAS J, ESTEVE-VIVES J et al.: Resource utilization and health care costs in patients diagnosed with Fibromyalgia in Spain. Clin Exp Rheumatol 2009; 27 (Suppl. 56): S39-S45.
13. SILVERMAN S, DUKES EM, JOHNSTON SS et al.: The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis. Curr Med Res Opin 2009; 25: 829-40.
14. BROWER W, RUTTEN F, KOOPMANSCHAP M: Costing in economics evaluations. In: M DRUMMOND, A MCGUIRE (Eds.). Economic evaluation in health care. OHE. Oxford University Press, 2001.
15. WOLFE F, SMYTHE HA, YUNUS MB et al.: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990; 33: 160-72.
16. VALLEJO MA, RIVERA J, ESTEVE-VIVES J et al.: Development of a self-reporting tool to obtain a Combined Index of Severity of Fibromyalgia (ICAF). HQLO 2010; 8: 2.
17. STEWART WF, LIPTON RB, SIMON D: Work-related disability: results from the American migraine study. Cephalalgia 1996; 16: 231-8.
18. CATÁLOGO DE ESPECIALIDADES FARMACÉUTICAS 2006: Consejo General de Colegios Oficiales de Farmacéuticos. Madrid, 2010; botplusweb.portalfarma.com. (accessed August, 17st 2010)
19. OBLIKUE CONSULTING, 2006: E-SALUD Base de datos de costes sanitarios. Available at: http://www.oblikue.com/bddcostes/
20. INE: Encuesta trimestral de coste laboral 2010. Available at: http://www.ine.es
21. CATÁLOGO NACIONAL DE OCUPACIONES: Instituto Nacional de Estadística. http://www.ine.es/
22. URIEL E, CONTRERAS D, MOLTÓ ML et al.: Econometria: el modelo lineal; In: URIEL E, CONTRERAS D, MOLTÓ ML, PEIRÓ A (Eds.): Econometría: el modelo lineal. Valencia, 1990, Editorial AC 412.
23. GREEN WH: Econometric Analysis. In: GREEN W (Ed.): Econometric Analysis (5th edition). New Jersey, Prentice Hall, 2003; p. 995.
24. PINDYCK RS, RUBINFELD DL (1998): Econometric Models and Economic Forecast, 4th edition. New York, McGraw-Hill. 520.
25. PENROD JR, BERNATSKY S, ADAM V, BARON M, DAYAN N, DOBKIN PL: Health services costs and their determinants in women with fibromyalgia J Rheumatol 2004; 31: 1391-8
26. KLEINMAN N, HARNETT J, MELKONIAN A et al.: Burden of fibromyalgia and comparisons with osteoarthritis in the workforce. J Occup Environ Med 2009; 51: 1384-93.
27. ANNEMANS L, WESSELY S, SPAEPEN E et al.: Health economic consequences related to the diagnosis of fibromyalgia syndrome. Arthritis Rheum 2008; 58: 895-902.
28. WHITE LA, ROBINSON R, YU AP et al.: Comparison of health care use and costs in newly diagnosed and established patients with fibromyalgia. J Pain 2009; 10: 976-83.
29. LURIE IZ, DUNLOP DD, MANHEIM LM: Trends in out-of-pocket medical care expenditures for Medicare-Age adults with arthritis between 1998 and 2004. Arthritis Rheum 2008; 58: 2236-40.